↓ Skip to main content

Cochrane Database of Systematic Reviews

Methotrexate for ankylosing spondylitis

Overview of attention for article published in Cochrane database of systematic reviews, February 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
14 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
157 Mendeley
Title
Methotrexate for ankylosing spondylitis
Published in
Cochrane database of systematic reviews, February 2013
DOI 10.1002/14651858.cd004524.pub4
Pubmed ID
Authors

Junmin Chen, Mirella MS Veras, Chao Liu, Junfang Lin

Abstract

Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown cause, characterized by sacroiliitis and spondylitis. Methotrexate (MTX), a widely used disease-modifying antirheumatic drug (DMARD), is effective for rheumatoid arthritis (RA), and so might work for AS. This is an update of a Cochrane review first published in 2004, and previously updated in 2006.

Twitter Demographics

The data shown below were collected from the profiles of 14 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Finland 1 <1%
Paraguay 1 <1%
Colombia 1 <1%
Switzerland 1 <1%
Unknown 153 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 18%
Student > Bachelor 24 15%
Researcher 17 11%
Student > Ph. D. Student 15 10%
Student > Postgraduate 14 9%
Other 28 18%
Unknown 30 19%
Readers by discipline Count As %
Medicine and Dentistry 67 43%
Nursing and Health Professions 13 8%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Agricultural and Biological Sciences 5 3%
Psychology 5 3%
Other 22 14%
Unknown 38 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 January 2020.
All research outputs
#1,776,575
of 16,682,934 outputs
Outputs from Cochrane database of systematic reviews
#4,345
of 11,568 outputs
Outputs of similar age
#17,371
of 157,264 outputs
Outputs of similar age from Cochrane database of systematic reviews
#37
of 109 outputs
Altmetric has tracked 16,682,934 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,568 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.4. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 157,264 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.